The Gross Law Firm
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HMPT, ATHA and BZ
NEW YORK, NY / ACCESSWIRE / July 21, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
Home Point Capital Inc. (NASDAQ:HMPT)
This lawsuit is on behalf of all persons and entities other than Defendants that purchased or otherwise acquired Home Point common stock pursuant and/or traceable to the Company's January 29, 2021 initial public offering.
A class action has commenced on behalf of certain shareholders in Home Point Capital Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Home Point's aggressive expansion of its broker partners would dramatically increase the Company's expenses; (ii) the mortgage industry was anticipating industry-wide decreased gain-on-sale margins as a result of rising interest rates in 2021 and Home Point would be subject to the same competitive pressures; (iii) accordingly, the Company had overstated its business and financial prospects; and (iv) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein.
Shareholders may find more information at https://securitiesclasslaw.com/securities/home-point-capital-inc-loss-submission-form/?id=17851&from=1
Athira Pharma, Inc. (NASDAQ:ATHA)
This lawsuit is on behalf of investors who purchased Athira Pharma, Inc. (NASDAQ: ATHA) between September 18, 2020 and June 17, 2021 and/or purchased common stock in or traceable to the Company's registration statement issued in connection with the Company's September 2020 initial public offering priced at $17.00 per share.
A class action has commenced on behalf of certain shareholders in Athira Pharma, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the research conducted by Defendant Kawas, which formed the foundation for Athira's product candidates and intellectual property, was tainted by Kawas' scientific misconduct, including the manipulation of key data through the altering of Western blot images; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and omitted material facts necessary in order to make the statements made not misleading.
Shareholders may find more information at https://securitiesclasslaw.com/securities/athira-pharma-inc-loss-submission-form/?id=17851&from=1
Kanzhun Limited (NASDAQ:BZ)
Investors Affected : June 11, 2021 - July 2, 2021
A class action has commenced on behalf of certain shareholders in Kanzhun Limited. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Kanzhun would face an imminent cybersecurity review by the Chinese government ("CAC"); (2) the CAC would require Kanzhun to suspend new user registration on its BOSS Zhipin app; (3) Kanzhun needed to "to conduct a comprehensive examination of cybersecurity risks"; (4) Kanzhun needed to "enhance its cybersecurity awareness and technology capabilities"; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Shareholders may find more information at https://securitiesclasslaw.com/securities/kanzhun-limited-loss-submission-form/?id=17851&from=1To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The Gross Law Firm
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Smart Eye25.11.2021 15:09:03 CET | Press release
Smart Eye completes the acquisition of iMotions
Bambuser AB25.11.2021 14:43:21 CET | Press release
BuzzFeed Taps Bambuser to Create Live Video Shopping Initiatives
STRAX25.11.2021 09:06:51 CET | Press release
Interim Report no. 3 for Financial Year 2021
BioInvent International25.11.2021 08:51:35 CET | Press release
Nomination Committee Appointed for BioInvent International’s Annual General Meeting 2022
Adverty AB25.11.2021 08:21:29 CET | Press release
Adverty Partners With Smart to Further Facilitate Access to Its Seamless in-Game Inventory
TECO 2030 ASA25.11.2021 07:01:35 CET | Press release
TECO 2030 is Leading a Project Group That Will Build A Hydrogen-Powered High-Speed Vessel For The Port of Narvik
Prospera Energy Inc.24.11.2021 14:31:51 CET | Press release
Prospera Energy Inc. Announces the Launch of New Website
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom